Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

Share Price is delayed by 15 minutes
Get Live Data
214.20    1.20 (0.56%)
Bid:
213.80
Ask:
214.20
Spread: 0.40 (0.187%)
Market Cap: £4.19b
CTEC Live PriceLast checked at - London Stock Exchange

Intraday ConvaTec Share Chart

Acquisition Completion of Triad Life Sciences Inc

14 Mar 2022 07:00

RNS Number : 6368E
ConvaTec Group PLC
14 March 2022
Β 

Β 

Β 

14 March 2022

Β 

ConvaTec Group completes acquisition of Triad Life Sciences Inc

Β 

Further to the announcement of 28 January 2022, ConvaTec Group Plc (CTEC:LON) is pleased to announce that it has completed the acquisition of Triad Life Sciences Inc ('Triad').

Β 

The Triad team, current portfolio and product pipeline will now transition to ConvaTec's Advanced Wound Care (AWC) business and be known as ConvaTec Advanced Tissue Technologies.

Β 

***

Β 

Contacts

AnalystsΒ &Β Investors

Kate Postans, Vice President of Investor Relations & Corporate Communications

+44 (0) 7826 447807

ir@convatec.com

Media

Buchanan: Charles Ryland / Chris Lane

+44 (0)207 466 5000

Β 

About ConvaTec

ConvaTec is a FTSE 250 global medical products and technologies company focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. We have more than 10,000 colleagues and sell our products and services in over 100 countries. Our vision isΒ Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. Group revenues in 2021 were over $2 billion. To learn more about ConvaTec, please visitΒ http://www.convatecgroup.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
ACQGPUQWWUPPUQC
Date   Source Headline
3rd Jul 20263:00 pmRNSHolding(s) in Company
30th Jun 20263:00 pmRNSHolding(s) in Company
25th Jun 202611:00 amRNSHolding(s) in Company
28th May 202611:00 amRNSHolding(s) in Company
27th May 202611:00 amRNSDirector/PDMR Shareholding
26th May 202611:00 amRNSHolding(s) in Company
21st May 20263:30 pmRNSResults of AGM
21st May 20267:00 amRNSAGM trading update for four months ended 30 April
13th Apr 202612:00 pmRNSProfessor Constantin Coussios steps down
9th Apr 20267:00 amRNSCapital Markets Day
17th Mar 20261:00 pmRNSNotice of AGM
17th Mar 202611:00 amRNSDirector/PDMR Shareholding
12th Mar 20262:30 pmRNSDirector/PDMR Shareholding
10th Mar 20261:00 pmRNSPublication of Annual Report
24th Feb 20267:00 amRNSConvatec FY25 Results
6th Feb 202611:00 amRNSHolding(s) in Company
2nd Jan 202611:00 amRNSTotal Voting Rights
19th Dec 202512:00 pmRNSHolding(s) in Company
19th Dec 202512:00 pmRNSHolding(s) in Company
17th Dec 20253:00 pmRNSHolding(s) in Company
10th Dec 20253:00 pmRNSHolding(s) in Company
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 202512:00 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 202511:00 amRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 202511:00 amRNSHolding(s) in Company
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20255:05 pmRNSHolding(s) in Company
24th Nov 20255:00 pmRNSHolding(s) in Company
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20255:30 pmRNSHolding(s) in Company
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20251:30 pmRNSHolding(s) in Company
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20256:00 pmRNSConvaTec Group
18th Nov 20257:00 amRNSPRICED SECONDARY OFFERING IN CONVATEC GROUP PLC
17th Nov 20254:57 pmRNSPROPOSED SECONDARY OFFERING IN CONVATEC GROUP PLC
14th Nov 20253:00 pmRNSHolding(s) in Company
13th Nov 20257:05 amRNSTransaction in Own Shares
13th Nov 20257:00 amRNSTrading update for 10 months ended 31 October 2025
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.